4.6 Review

Imaging-Based Neurochemistry in Schizophrenia: A Systematic Review and Implications for Dysfunctional Long-Term Potentiation

期刊

SCHIZOPHRENIA BULLETIN
卷 41, 期 1, 页码 44-56

出版社

OXFORD UNIV PRESS
DOI: 10.1093/schbul/sbu132

关键词

schizophrenia; long-term potentiation; glutamate; dopamine; GABA; MRS; PET; SPECT

资金

  1. Ontario Graduate Scholarship
  2. Ontario Mental Health Foundation (OMHF) Scholarship
  3. Brain Canada
  4. Brain and Behavior Research Foundation
  5. Canadian Foundation for Innovation
  6. Canadian Institutes of Health Research (CIHR)
  7. Ontario Ministry of Health and Long-Term Care
  8. Ontario Ministry of Research and Innovation
  9. US National Institute of Health (NIH)
  10. W. Garfield Weston Foundation
  11. NIH
  12. CIHR
  13. OMHF
  14. CONACyT
  15. ICyTDF
  16. Brain & Behavior Research Foundation (NARSAD)
  17. Janssen
  18. BrainswayInc
  19. SepracorInc
  20. AstraZeneca

向作者/读者索取更多资源

Cognitive deficits are commonly observed in patients with schizophrenia. Converging lines of evidence suggest that these deficits are associated with impaired long-term potentiation (LTP). In our systematic review, this hypothesis is evaluated using neuroimaging literature focused on proton magnetic resonance spectroscopy, positron emission tomography, and single-photon emission computed tomography. The review provides evidence for abnormal dopaminergic, GABAergic, and glutamatergic neurotransmission in antipsychotic-naive/free patients with schizophrenia compared with healthy controls. The review concludes with a model illustrating how these abnormalities could lead to impaired LTP in patients with schizophrenia and consequently cognitive deficits.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据